Please use this identifier to cite or link to this item:
http://142.54.178.187:9060/xmlui/handle/123456789/18089Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Khurshid Ahmad | - |
| dc.date.accessioned | 2023-03-09T04:27:15Z | - |
| dc.date.available | 2023-03-09T04:27:15Z | - |
| dc.date.issued | 1999-10-09 | - |
| dc.identifier.citation | Ahmad, K. (1999). In vivo pathogenicity of hydropericardium-hepatitis syndrome (Angara disease) and efficacy of vaccines. Pakistan Veterinary Journal, 19(4), 200-203. | en_US |
| dc.identifier.issn | 0253-8313 | - |
| dc.identifier.uri | http://142.54.178.187:9060/xmlui/handle/123456789/18089 | - |
| dc.description.abstract | The pathogenicity of recent field isolate (PRI-10) of Hydropericardium-Hepatitis Syndrome (HHS) showed reduced pathogenicity as compared to the isolates studied on the inception of the syndrome in 1987-88. Formalinized vaccines for HHS including Aqua Base Liver Organ (ABLO) vaccine and Oil Base Tissue Culture (OBTC) vaccine are effective for the control of the syndrome. ABLO vaccine gives an early immune response as compared to OBTC vaccine, but OBTC vaccine gives better immune response. The vaccination against HHS has positive effect on the immune response of the chicks against Newcastle disease virus, | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Faisalabad: Faculty of Veterinary Science University of Agriculture Faisalabad | en_US |
| dc.title | IN VIVO PATHOGENICITY OF HYDROPERICARDIUM-HEPATITIS SYNDROME (ANGARA DISEASE) AND EFFICACY OF VACCINES | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Issue 04 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 200-203.htm | 119 B | HTML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.